UBC PiMS Research Group

Pharmacoepidemiology in Multiple Sclerosis Research Group

Association between anti-depressants drugs on the progression of multiple sclerosis.

Researchers found no evidence to suggest that exposure to the antidepressants ‘selective serotonin reuptake inhibitors’ were associated with a delay in MS disability accumulation or progression.

Unique Relationship Found Between Gut Microbiota and Immune Markers in Kids with MS

Children with multiple sclerosis (MS) may show a disruption in the balance of bacteria in the gut as early as two years into the disease course, suggests new findings from Dr. Helen Tremlett.

Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls

Dr. Helen Tremlett's latest article has been published in BMC Neurology.

PiMS Group Featured in MS Discovery Podcasts

The PiMS research group was recently featured by the MS Discovery Forum. Drs. Kowalec, Razaz and Kingwell spoke about their respective research topics, which were presented at the ECTRIMS 2015 annual congress in Barcelona. Please visit the following links for the podcasts: Dr. Neda Razaz on children of parents with MS: http://www.msdiscovery.org/news/podcasts/27617-episode-67-neda-razaz-children-parents-ms Dr. Elaine Kingwell on MS trends […]
❙ ❙ « 1 / 4 »

Welcome to the new UBC PiMS Group Website

Our Research Group is physically located within the University of British Columbia’s hospital. We are also part of the Brain Research Centre, Faculty and Department of Medicine and Division of Neurology. If that wasn’t enough, we are also affiliated with the Vancouver Coastal Health Research Institute.

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia